264 related articles for article (PubMed ID: 21392565)
1. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs].
Chen XX; Yuan S; Li G; Liang YY; Zhou X; Xie CS; Long CF
Zhong Yao Cai; 2011 May; 34(5):750-3. PubMed ID: 21954564
[TBL] [Abstract][Full Text] [Related]
3. Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion.
Yu A; Wang H; Wang J; Cao F; Gao Y; Cui J; Zhai G
J Pharm Sci; 2011 Mar; 100(3):933-41. PubMed ID: 20862776
[TBL] [Abstract][Full Text] [Related]
4. Metabolic profile of puerarin in rats after intragastric administration of puerarin solid lipid nanoparticles.
Luo CF; Hou N; Tian J; Yuan M; Liu SM; Xiong LG; Luo JD; Chen MS
Int J Nanomedicine; 2013; 8():933-40. PubMed ID: 23486407
[TBL] [Abstract][Full Text] [Related]
5. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
Quan DQ; Xu GX
Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
[TBL] [Abstract][Full Text] [Related]
6. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats.
Zhang Z; Bu H; Gao Z; Huang Y; Gao F; Li Y
Int J Pharm; 2010 Jul; 394(1-2):147-53. PubMed ID: 20435111
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles following oral administration.
Wang F; Cao J; Hao J; Liu K
J Microencapsul; 2014; 31(4):382-9. PubMed ID: 24697172
[TBL] [Abstract][Full Text] [Related]
8. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry.
Cui S; Zhao C; Tang X; Chen D; He Z
Biomed Chromatogr; 2005 Jun; 19(5):375-8. PubMed ID: 15627278
[TBL] [Abstract][Full Text] [Related]
9. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation.
Liao D; Liu X; Dai W; Tang T; Ou G; Zhang K; Han M; Kang R; Yang S; Xiang D
Drug Deliv; 2015; 22(4):516-21. PubMed ID: 24467620
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of puerarin liposome and its oral absorption in rat].
Gu YZ; Zhou W; Zhai GX
Zhong Yao Cai; 2007 Aug; 30(8):970-3. PubMed ID: 18074848
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
Manjunath K; Venkateswarlu V
J Control Release; 2005 Oct; 107(2):215-28. PubMed ID: 16014318
[TBL] [Abstract][Full Text] [Related]
12. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model.
Dong Z; Guo J; Xing X; Zhang X; Du Y; Lu Q
Biomed Pharmacother; 2017 May; 89():297-304. PubMed ID: 28236703
[TBL] [Abstract][Full Text] [Related]
13. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.
Zhang Y; Wang R; Wu J; Shen Q
Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381
[TBL] [Abstract][Full Text] [Related]
14. Metabolites of puerarin identified by liquid chromatography tandem mass spectrometry: similar metabolic profiles in liver and intestine of rats.
Luo CF; Yuan M; Chen MS; Liu SM; Ji H
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):363-70. PubMed ID: 20006564
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Tissue Distribution Kinetics of Puerarin in Rats Using Indirect Competitive ELISA.
Kong H; Wang X; Shi R; Zhao Y; Cheng J; Yan X; Liu X; Wang Y; Zhang M; Wang Q; Qu H
Molecules; 2017 Jun; 22(6):. PubMed ID: 28587251
[TBL] [Abstract][Full Text] [Related]
16. [Study on pharmacokinetics of puerarin in rats following different methods of administration of Tongqiao Sanyu prescription].
Chen X; Du S; Lu Y; Zhao X; Wang S; Li P; Song X
Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(17):2347-9. PubMed ID: 22121800
[TBL] [Abstract][Full Text] [Related]
17. [Effect of verapamil on pharmacokinetics of puerarin in rats].
Cui SM; Ma YB
Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):2033-6. PubMed ID: 19086648
[TBL] [Abstract][Full Text] [Related]
18. Effects of poly(amidoamine) dendrimers on ocular absorption of puerarin using microdialysis.
Yao C; Wang W; Zhou X; Qu T; Mu H; Liang R; Wang A; Sun K
J Ocul Pharmacol Ther; 2011 Dec; 27(6):565-9. PubMed ID: 21895496
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic study of puerarin in rat serum by liquid chromatography tandem mass spectrometry.
Prasain JK; Peng N; Acosta E; Moore R; Arabshahi A; Meezan E; Barnes S; Wyss JM
Biomed Chromatogr; 2007 Apr; 21(4):410-4. PubMed ID: 17221935
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of puerarin in dog plasma by HPLC and study on the relative bioavailability of sustained release tablets.
Ren F; Jing Q; Shen Y; Ma H; Cui J
J Pharm Biomed Anal; 2006 May; 41(2):549-53. PubMed ID: 16413737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
